CD66e Monoclonal Antibody

This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

Introducing the CD66E Monoclonal Antibody, a cutting-edge product designed to revolutionize the field of immunology. This highly specific antibody is meticulously engineered to target the CD66E antigen, a cell surface glycoprotein that plays a crucial role in various physiological processes.

The CD66E Monoclonal Antibody boasts exceptional affinity and selectivity, ensuring accurate and reliable detection of CD66E expression in a wide range of biological samples. Its superior binding properties enable precise identification and quantification of CD66E-positive cells, facilitating comprehensive research in diverse areas such as cancer biology, immunotherapy, and infectious diseases.

Crafted with utmost precision, this antibody exhibits exceptional reproducibility and consistency, guaranteeing consistent results across experiments. Its robust performance is further enhanced by its exceptional stability, allowing for long-term storage without compromising its efficacy.

The CD66E Monoclonal Antibody is meticulously validated through rigorous quality control measures, ensuring its reliability and reproducibility. Its exceptional specificity is confirmed through various techniques, including flow cytometry, immunohistochemistry, and Western blotting, providing researchers with utmost confidence in their experimental outcomes.

This groundbreaking product is offered in various formats, including purified antibody, conjugated antibody, and antibody pairs, catering to diverse experimental requirements. Its versatility extends to multiple species, making it suitable for a wide range of research applications.

In summary, the CD66E Monoclonal Antibody represents a significant advancement in the field of immunology, offering researchers a powerful tool to unravel the complexities of CD66E biology. With its exceptional specificity, reproducibility, and versatility, this antibody is poised to revolutionize scientific investigations and pave the way for groundbreaking discoveries.